CIC Clinical Trials

225 recruitingLast updated: July 25, 2026

There are 225 actively recruiting cic clinical trials across 39 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include New York, New York, United States, Houston, Texas, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


CIC Trials at a Glance

225 actively recruiting trials for cic are listed on ClinicalTrialsFinder across 6 cities in 39 countries. The largest study group is Not Applicable with 93 trials, with the heaviest enrollment activity in New York, Houston, and Boston. Lead sponsors running cic studies include M.D. Anderson Cancer Center, Centre Hospitalier Universitaire, Amiens, and Cairo University.

Treatments under study

About CIC Clinical Trials

Looking for clinical trials for CIC? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new CIC trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about CIC clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 225 trials

Recruiting
Phase 1

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

Gastroesophageal Junction AdenocarcinomaClinical Stage II Esophageal Adenocarcinoma AJCC v8Clinical Stage III Esophageal Adenocarcinoma AJCC v8+10 more
M.D. Anderson Cancer Center24 enrolled1 locationNCT04615013
Recruiting

Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining

Thoracic CancersLung Cancer NOSMalignant Pleural Mesotheliomas NOS+2 more
National Cancer Institute (NCI)1,559 enrolled1 locationNCT00242723
Recruiting

Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight

SYNGAP1-Related Intellectual DisabilityDLG4FOXP1+184 more
Simons Searchlight100,000 enrolled2 locationsNCT01238250
Recruiting
Not Applicable

Study on Adjuvant Chemotherapy After Total Two-field Lymph Node Dissection of Thoracic Esophageal Squamous Cell Carcinoma

Thoracic Esophageal Squamous Cell Carcinoma
Sun Yat-Sen University Cancer Center232 enrolled1 locationNCT04174079
Recruiting

Genome Transplant Dynamics

Thoracic Organ Transplantation
National Heart, Lung, and Blood Institute (NHLBI)991 enrolled6 locationsNCT02423070
Recruiting
Not Applicable

Transversus Thoracic Muscle Plane Block Versus Pectointercostal Fascial Block for Enhanced Recovery After Cardiac Surgery

Cardiac SurgeryTransversus Thoracic Muscle Plane BlockPecto-intercostal Fascial Block+1 more
Assiut University90 enrolled1 locationNCT07417462
Recruiting
Phase 1

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+71 more
M.D. Anderson Cancer Center43 enrolled1 locationNCT05092373
Recruiting

FDG PET/MR Imaging of Peripheral Pain Generators

PainNociceptive Pain
University of Wisconsin, Madison128 enrolled1 locationNCT06171659
Recruiting
Not Applicable

Improving Thoracic Surgical Care Using Electronic Patient-Reported Outcomes (ePROS)

Thoracic
UNC Lineberger Comprehensive Cancer Center200 enrolled1 locationNCT06075316
Recruiting
Not Applicable

Clinical Study of a New Treatment Model for Elderly Lung Cancer Patients

Lung NeoplasmPerioperative CareAged+2 more
Peking University People's Hospital1,000 enrolled1 locationNCT07632664
Recruiting
Phase 1

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

Malignant Neoplasm of Bone and Articular CartilageMalignant Neoplasms of Female Genital OrgansMalignant Neoplasms of Independent (Primary) Multiple Sites+7 more
M.D. Anderson Cancer Center44 enrolled1 locationNCT03093909
Recruiting
Phase 2

Deucravacitinib in the Treatment of Cicatricial Alopecias

Central Centrifugal Cicatricial AlopeciaFrontal Fibrosing Alopecia
Icahn School of Medicine at Mount Sinai20 enrolled1 locationNCT07508488
Recruiting
Phase 2

Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris

Central Centrifugal Cicatricial AlopeciaLichen Planopilaris
Icahn School of Medicine at Mount Sinai30 enrolled1 locationNCT07487948
Recruiting

LUCINAE Registry: Thoracic Cancers During Pregnancy

Lung CancerThoracic CancerCancer During Pregnancy
Oncology Institute of Southern Switzerland100 enrolled4 locationsNCT07699861
Recruiting
Not Applicable

A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

Ovarian CancerMelanomaHead and Neck Cancer+5 more
Memorial Sloan Kettering Cancer Center324 enrolled7 locationsNCT05053230
Recruiting
Phase 2

Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients

Limited Stage Small Cell Lung CancerThoracic NeoplasmsRespiratory Tract Neoplasms+1 more
Fundación GECP37 enrolled20 locationsNCT07242547
Recruiting

Prospective Data Collection Initiative on Thoracic Malignancies

Lung CancerThoracic CancerThymus Cancer+5 more
Dutch Society of Physicians for Pulmonology and Tuberculosis12,000 enrolled23 locationsNCT06996249
Recruiting
Not Applicable

Cardiac Contractility Modulation in Chagas Heart Disease

Heart FailureSystolic DysfunctionChagas Cardiomyopathy+2 more
InCor Heart Institute60 enrolled1 locationNCT05519046
Recruiting
Not Applicable

A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta

Aortic AneurysmAortic DiseasesAortic Aneurysm and Dissection+3 more
Vascutek Ltd.150 enrolled22 locationsNCT07078383
Recruiting

Accessing the Clarity and Acceptability of Recruitment Materials for a Study on Thoracic Aortic Disease Surveillance

Thoracic Aortic Disease
University of Nottingham30 enrolled1 locationNCT07574151